Court Rejects Teva’s Arguments, Invalidates Its Crestor Patent

A federal appeals court has affirmed a lower court decision invalidating Teva’s stabilizing formulation patent for blockbuster AstraZeneca cholesterol drug Crestor.
Generic Line